How to Read a Peptide COA: HPLC Purity, LC-MS Identity & What Researchers Should Look For

Many researchers ask how to read a peptide coa. When evaluating research peptides, one of the most important documents a researcher can review is the Certificate of Analysis (COA).

A COA provides analytical information about a particular batch or lot of material and can help researchers evaluate characteristics such as identity, purity, molecular mass, batch number, testing methods, analytical results, specifications, and release information.

However, simply seeing “≥99% purity” on a document does not tell the entire story. Understanding how that number was determined, what analytical methods were used, whether the testing corresponds to the actual batch, and what additional characterization is available can provide a much more complete picture.

For peptide researchers, two analytical techniques frequently encountered are HPLC and mass spectrometry (MS / LC-MS). These techniques answer different questions. HPLC is commonly used to evaluate chromatographic purity and separate related substances, while mass spectrometry can provide highly specific molecular-mass information useful for identity confirmation.

This guide explains how researchers can interpret the major components of a peptide COA and what each result actually tells them. For a closer look at the purity number itself, see What Does 99% HPLC Purity Mean?

What Is a Certificate of Analysis?

A Certificate of Analysis, commonly abbreviated COA, is a document containing analytical results and specifications associated with a particular batch of material. A properly documented COA may include:

The importance of batch-specific documentation is recognized throughout analytical and quality systems. FDA guidance on analytical procedures emphasizes the importance of analytical methods for determining characteristics such as identity, strength, quality, purity, and potency. FDA GMP guidance also describes COAs as documents that should contain the tests performed, acceptance limits, and numerical results where applicable.

Step 1: Check the Product and Batch Number

The first thing to examine is surprisingly simple: does the COA actually correspond to the material being evaluated?

Look for product name, catalog number, batch number, lot number, testing date, and manufacturer or testing laboratory. The batch/lot number is particularly important. A COA showing 99% purity is much more useful when the researcher can establish that the result corresponds to the specific lot being evaluated.

FDA’s GLP information similarly emphasizes that the identity and characteristics of test articles should be determined and documented for each batch.

Why this matters

Imagine two batches: Batch A at 99.4% purity and Batch B at 98.7% purity. A COA from Batch A should not automatically be interpreted as evidence that Batch B has the same analytical characteristics. This is why batch-specific documentation matters.

Step 2: Understanding HPLC Purity

One of the most commonly reported numbers on peptide COAs is HPLC purity. HPLC stands for high-performance liquid chromatography. The technique separates chemical components based on their interactions with the chromatographic system. For peptide analysis, reversed-phase HPLC is commonly used.

Conceptually, the sample enters the chromatographic system and individual components separate over time. The detector then produces a chromatogram. Researchers can examine the main peptide peak, retention time, secondary peaks, peak areas, and overall chromatographic profile.

The reported purity percentage is typically calculated from the relative chromatographic response under the specified method. For example, if the main peak is 99.2% and other detected peaks are 0.8%, the reported chromatographic purity may be 99.2%.

What “99% HPLC Purity” Does Not Mean

This is one of the most important points in the entire article. A statement such as ≥99% HPLC purity does not automatically mean:

• 99% absolute chemical content
• 99% biological activity
• 99% sequence confirmation
• 99% sterility
• 99% absence of endotoxin
• 99% absence of every possible contaminant

HPLC purity is specifically associated with the analytical method used. The method’s ability to separate and detect related substances matters. FDA guidance emphasizes that analytical procedures should be appropriately developed and validated for their intended purpose, including the ability to distinguish the desired product from impurities and degradation products.

Step 3: Understanding LC-MS Identity Testing

Another important analytical technique is LC-MS. Liquid chromatography–mass spectrometry combines chromatographic separation with mass spectrometric detection. It can provide information about the molecular mass of the detected peptide.

This makes LC-MS particularly useful for investigating whether the measured material is consistent with the expected molecular identity. Research describing analytical strategies for synthetic peptide reference standards specifically identifies mass spectrometry as an important identity-characterization technique alongside chromatography.

Molecular Weight: Calculated vs. Observed

A peptide has a theoretical molecular mass based on its amino-acid sequence and chemical modifications. A mass-spectrometry analysis might produce an experimentally observed value close to that expected mass. Researchers can then compare expected mass vs. observed mass. A close correspondence supports the proposed molecular identity.

However, mass alone does not necessarily prove the entire sequence. This is an important analytical distinction.

Sequence Identity vs. Molecular Mass

Consider two peptides with similar molecular masses. A mass measurement alone might not completely distinguish between them. Therefore, researchers should understand that molecular mass confirmation and complete sequence characterization are related but not necessarily identical analytical questions.

Depending on the research objective, additional analytical techniques may be appropriate. This is one reason peptide characterization often uses orthogonal analytical methods rather than relying on a single measurement.

What Is Orthogonal Testing?

Orthogonal testing means using different analytical methods that provide complementary information.

• HPLC can provide information about chromatographic purity and separation.
• LC-MS can provide molecular-mass information and support identity characterization.
• Additional methods may address sequence confirmation, structural characterization, impurity profiling, water content, residual solvents, counterions, aggregation, or stability.

The underlying principle is straightforward: different analytical methods answer different questions. A strong characterization strategy therefore does not ask one test to answer everything.

HPLC vs. LC-MS

Neither technique should automatically be considered “better.” They provide different information. Additional context is available in Peptide Purity, HPLC, LC-MS & COAs.

Step 4: Look at the Actual Chromatogram

A COA that reports “Purity: ≥99%” provides one piece of information. A researcher may also want to know whether an actual chromatogram is available. A chromatogram can provide visual information about the main peak, retention time, secondary peaks, peak shape, baseline, and separation.

This is particularly useful because the number alone does not show the underlying chromatographic profile. A result might say “Purity: 99.1%,” but the chromatogram can help researchers see how that result was generated.

Step 5: Check the Molecular Weight

The molecular-weight section of a COA should be compared with the expected molecular mass. Researchers may see terminology such as calculated molecular weight, observed molecular weight, expected molecular mass, or measured molecular mass. The terminology can vary between laboratories.

The important question is: does the measured result correspond appropriately to the expected molecular identity? Mass spectrometry is particularly useful for this type of characterization because of its selectivity and sensitivity for peptide analysis.

Step 6: Look for Specifications and Results

A strong COA should distinguish between specification (what the material is required to meet) and result (what the laboratory actually measured).

“Pass” tells you the material met a requirement. A numerical result tells you what was actually measured. FDA GMP guidance specifically describes COAs as including tests performed, acceptance limits, and numerical results when those results are numerical.

Step 7: Understand the Testing Laboratory

Researchers should also pay attention to who performed the testing. A COA may identify a manufacturer laboratory, independent analytical laboratory, contract testing organization, or quality-control laboratory.

Third-party testing can provide useful independent analytical information. However, the presence of a third-party laboratory name alone does not establish that every analytical method is appropriate or that every result is independently verified.

Researchers should still examine the method used, sample identification, batch number, test date, specifications, and actual results.

Step 8: Don’t Ignore the Testing Method

A COA may say “HPLC ≥99%.” Ideally, the researcher should also be able to determine what type of HPLC, what column, what detection wavelength, what mobile phase, what gradient, what retention time, and what calculation method.

The exact level of detail available will depend on the laboratory and the purpose of the document. The broader point is: an analytical result has meaning only in the context of the method that produced it. FDA analytical-method guidance emphasizes method development and validation as important components of reliable analytical characterization.

Step 9: Consider Stability

A peptide can meet specifications when tested and still change over time. Potential stability considerations include temperature, moisture, light, oxidation, hydrolysis, aggregation, freeze-thaw exposure, and storage duration.

This is why a COA should not be interpreted as a permanent guarantee that a material will remain unchanged indefinitely. The testing date and storage conditions therefore matter. See the Peptide Storage & Handling Guide.

Lyophilized Peptides

Many research peptides are supplied as lyophilized powder. Lyophilization, commonly called freeze-drying, removes water under controlled conditions. This can improve the practical storage stability of many peptide preparations. However, lyophilization does not eliminate the need for appropriate storage.

Researchers should follow the supplier’s documented storage requirements and avoid unnecessary exposure to heat, moisture, light, and repeated temperature changes.

Step 10: What About Sterility and Endotoxin?

This is another critical distinction. HPLC purity does not establish sterility. LC-MS identity does not establish sterility. And neither test alone establishes endotoxin status.

Sterility and endotoxin are separate analytical considerations requiring appropriate methods. This distinction becomes particularly important when researchers are designing experiments involving cell culture or other sensitive biological systems. A peptide can have excellent chromatographic purity while still requiring additional characterization for a specific experimental application.

Why Purity Isn’t the Same as Biological Activity

Another common misconception is that higher purity automatically means stronger biological activity. Not necessarily.

Biological activity can depend on molecular identity, correct sequence, folding or conformation where relevant, chemical modifications, aggregation, stability, experimental conditions, target system, and concentration. A 99% HPLC result is therefore only one component of the overall characterization picture.

A Better Way to Think About Peptide Quality

Rather than asking “Is this peptide 99% pure?”, researchers can ask: “What evidence supports the identity, purity, and characteristics of this specific batch?”

This approach is much more informative than focusing on a single percentage.

Why Batch-to-Batch Consistency Matters

Imagine a researcher performs an experiment using Batch A and obtains a particular result. Several months later, they repeat the experiment using Batch B. If the analytical characteristics differ significantly, reproducing the experiment may become more difficult.

This is why batch identification and documentation are important for reproducibility. FDA GMP guidance discusses assigning distinctive batch identifiers and maintaining systems for identifying the status of each batch.

What Should Researchers Look for on a COA?

• Product identity — is the compound clearly identified?
• Batch number — does the COA correspond to the actual batch?
• Test date — when was the material analyzed?
• HPLC purity — what purity was measured?
• HPLC method — what analytical method was used?
• Molecular mass — does the observed mass correspond to the expected value?
• Identity testing — is there independent evidence supporting identity?
• Specifications — what acceptance criteria were applied?
• Actual results — are numerical results provided?
• Testing laboratory — who performed the analysis?
• Additional characterization — are other relevant tests reported?

Frequently Asked Questions

How Summit Pep Labs Approaches COA Documentation

For research materials, analytical documentation is an important part of reproducibility. At Summit Pep Labs, the goal is to provide researchers with batch-specific documentation that makes it easier to review analytical characteristics before beginning experimental work.

Depending on the material, documentation may include information regarding HPLC purity, molecular mass, identity, batch number, testing date, analytical methods, and product specifications. Researchers should always evaluate the documentation in the context of their own experimental requirements.

Related Reading on Summit Pep Labs

• What Does 99% HPLC Purity Mean?
• Peptide Purity, HPLC, LC-MS & COAs
• Peptide Storage & Handling Guide
• Lyophilized Peptides Explained
• Peptide Half-Life Explained
• GHK-Cu Research Guide
• Ultimate Retatrutide Research Guide
• Tesamorelin Research Guide
• Cagrilintide Research Guide
• KLOW Peptide Research Guide
• GLOW Peptide Research Guide

Final Thoughts

A Certificate of Analysis is more than a single number printed at the bottom of a document. For researchers, the most useful COA is one that allows them to understand what was tested, which batch was tested, how it was tested, what specification was applied, what the actual result was, and what that result does and does not establish.

HPLC and LC-MS are particularly useful because they provide complementary information. HPLC helps researchers evaluate chromatographic separation and purity. LC-MS can provide molecular-mass information that supports identity characterization. Additional analytical testing can provide further information depending on the compound and research application.

The most important principle is simple: a peptide should be evaluated using the complete analytical picture rather than a single purity percentage. For researchers interested in reproducibility, batch documentation and appropriate analytical characterization are fundamental components of good experimental practice.